Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Bullboard Posts
Comment by whatdoiknow123on Jul 28, 2020 1:16pm
177 Views
Post# 31331729

RE:Market games

RE:Market gamesThe article is so obviously biased that it is clearly designed to sow as much doubt in as many ways as possible and the main giveaways are:

1. the intent to denigrate the intentions of the management by portraying them as incompetent and corrupt when there is absolutely no evidence of that and when the accounts of an emerging Biosciences Company in the early stages usually look exactly so.
2. The intentional attempt to mislead by claiming that several companies have already achieved FDA approval and so beaten SONA to the startline when those tests are not in competetion to Sona´s, are no use in Mass Screening and the two that are Antigen Tests are clearly inferior .
3. He makes no reference to the movement towards Screening nor any mention of Rockefeller and Gates Foundations support of Antigen Testing nor other Organisations such as NIH and EU.
4 He uses one report that suggests a 4.22 billion total market when most serious Organisations are talking about the USA target alone of carrying out at least 30 million tests per week with much more than double that predicted worldwide. That comes to a minimum of 3 billion tests over a 12 month period ( and possibly much more) with a total market in the range of 60-100 billion or perhaps much more. Rockefeller suggested that the USA alone needed to set aside 75 billion for their Screening Programme.

The giveway at the end was his declaration as a shorter which really was not necessary as it was already so obvious long before the end of the article.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse